PYC pyc therapeutics limited

There are a number of fairly recently filed patent applications...

  1. 6,297 Posts.
    lightbulb Created with Sketch. 22344
    There are a number of fairly recently filed patent applications relevant to the company’s current programs. PYC has also filed for patent protection for its newly announced drug candidate (PYC-001 for Diabetic Retinopathy and nAMD). Expiry date for that should be 2039.

    Vision Pharma/Murdoch University (Expiring 2038)
    Novel Retinitis Pigmentosa Treatment Application Number 2019901804

    PYC Therapeutics (Expiring 2038)
    Novel Cellular Delivery Methods Application Number 2019904883
    Novel Cellular Delivery methods Application Number 2019904882

    Phylogica (Expiring 2037)
    Cell Penetrating Peptides and Related Compositions and Methods
    International Application No.PCT/AU2018/050781

    https://patentscope.wipo.int/search/en/search.jsf
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.20
Change
0.050(4.35%)
Mkt cap ! $699.9M
Open High Low Value Volume
$1.16 $1.21 $1.13 $387.7K 327.1K

Buyers (Bids)

No. Vol. Price($)
1 2000 $1.12
 

Sellers (Offers)

Price($) Vol. No.
$1.20 25000 1
View Market Depth
Last trade - 16.10pm 23/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.